AbCellera Biologics Inc. (ABCL): A Bull Case Theory

We came across a bullish thesis on AbCellera Biologics Inc. (ABCL) on Twitter by Jack Prescott. In this article, we will summarize the bulls’ thesis on ABCL. AbCellera Biologics Inc. (ABCL)’s share was trading at $2.94 as of Jan 16th. ABCL’s trailing P/E was 19.92 according to Yahoo Finance.

A data scientist standing in front of a large monitor presenting a drug discovery analysis.

AbCellera is a biotechnology company that specializes in antibody discovery using cutting-edge...